Table 1 Association between the expression of USP5 and clinicopathological parameters in NSCLC

All case

19 (23.2%)

63 (76.8%)

Gender

0.5570

 Male

12 (63.2%)

35 (55.6%)

 Female

7 (36.8%)

28 (44.4%)

Age

0.6727

 < 60

11 (57.9%)

33 (52.4%)

 ≥ 60

8 (42.1%)

30 (47.6%)

Pathological grading

0.6103

 I

2 (10.5%)

6 (9.5%)

 II

12 (63.2%)

31 (49.2%)

 III

5 (26.3%)

26 (41.3%)

Tumor size (T)

0.0252^a

 1

8 (42.1%)

8 (12.7%)

 2

9 (47.4%)

35 (55.6%)

 3

2 (10.5%)

16 (25.4%)

 4

0 (0%)

4 (6.3%)

EGFR

0.5278

 Negative

12 (92.3%)

40 (80.0%)

 Positive

1 (7.9%)

10 (20.0%)

ALK

0.8694

 Negative

11 (78.6%)

43 (81.1%)

 Positive

3 (21.4%)

10 (18.9%)